Sinopharm Group Co. Ltd. (HKG:1099)
20.36
+0.22 (1.09%)
At close: Dec 12, 2025
Sinopharm Group Market Cap
Sinopharm Group has a market cap or net worth of 63.54 billion as of December 12, 2025. Its market cap has decreased by -0.92% in one year.
Market Cap
63.54B
Enterprise Value
166.73B
Revenue
626.85B
Ranking
n/a
PE Ratio
8.21
Stock Price
20.36
Market Cap Chart
Since September 23, 2009, Sinopharm Group's market cap has increased from 40.42B to 63.54B, an increase of 57.18%. That is a compound annual growth rate of 2.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 63.54B | -4.41% |
| Dec 31, 2024 | 66.47B | 4.16% |
| Dec 29, 2023 | 63.82B | 3.07% |
| Dec 30, 2022 | 61.91B | 16.98% |
| Dec 31, 2021 | 52.93B | -10.07% |
| Dec 31, 2020 | 58.86B | -30.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 277.87B |
| Hansoh Pharmaceutical Group Company | 262.50B |
| JD Health International | 184.89B |
| Innovent Biologics | 143.36B |
| WuXi Biologics | 138.21B |
| Sino Biopharmaceutical | 120.31B |
| Akeso | 108.14B |
| Sichuan Kelun-Biotech Biopharmaceutical | 97.38B |